Norethindrone acetate enhances the antiatherogenic effect of 17beta-estradiol: a secondary prevention study of aortic atherosclerosis in ovariectomized cholesterol-fed rabbits

Arteriosclerosis, Thrombosis, and Vascular Biology
Peter AlexandersenC Christiansen

Abstract

The influence of progestogens in combination with 17beta-estradiol (E2) on cardiovascular disease remains controversial. This study investigated the effect of norethindrone acetate (NETA) combined with E2 on aortic atherosclerosis. Eighty mature female rabbits were ovariectomized, then fed a cholesterol-rich diet (240 mg/d) for 14 weeks to induce aortic atherosclerosis. They were randomized to four equally large groups for the following 38-week intervention period. One group received placebo, another group oral E2 4 mg daily (E2), and the last two groups oral E2 4 mg daily combined with either NETA 1 mg (E2NETA1) or NETA 3 mg (E2NETA3). The cholesterol intake was reduced to a "maintenance" level of 80 mg/d during the intervention period. Total serum cholesterol and ultracentrifuged lipoproteins were analyzed enzymatically throughout the study. The cholesterol content in the aortic wall was 2.76+/-0.44 micromol/cm2 (mean+/-SEM) in the E2NETA1 group, 1.77+/-0.37 micromol/cm2 in the E2NETA3 group, 5.46+/-0.77 micromol/cm2 in the E2 group, and 7.20+/-0.94 micromol/cm2 in the placebo group (ANOVA P<0.0001). The difference (in the aortic cholesterol accumulation) between the E2 and each of the combined E2/NETA groups was statisticall...Continue Reading

References

Dec 1, 1975·Clinical Biochemistry·G E AbrahamG B Maroulis
Oct 1, 1992·British Journal of Obstetrics and Gynaecology·M FalkebornT Naessén
Sep 21, 1991·BMJ : British Medical Journal·E FarishD M Hart
Oct 1, 1990·The Journal of Clinical Endocrinology and Metabolism·C Christiansen, B J Riis
Sep 1, 1990·Maturitas·P M Sarrel
Nov 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·M R AdamsT B Clarkson
Apr 30, 1987·The New England Journal of Medicine·G A ColditzC H Hennekens
Dec 1, 1983·European Journal of Clinical Investigation·L FåhraeusL Wallentin
Mar 5, 1981·The New England Journal of Medicine·E HirvonenV Manninen
Dec 1, 1994·Journal of the American College of Cardiology·J K WilliamsT B Clarkson
Aug 15, 1996·The New England Journal of Medicine·F GrodsteinC H Hennekens

❮ Previous
Next ❯

Citations

Jun 19, 2004·International Journal of Cardiology·Jaffar Ali RazaAssad Movahed
Jul 11, 2002·The American Journal of Cardiology·Peter Collins
Dec 12, 2003·Steroids·Thomas B Clarkson, Susan E Appt
Jun 8, 2001·Maturitas·C Christiansen
Jan 9, 2001·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·S L HouserA D Schreiber
Dec 3, 1999·Journal of Internal Medicine·O NygårdP M Ueland
Mar 21, 2002·Journal of Internal Medicine·B Guzic-SalobirL Vrabic
Jun 26, 2002·Menopause : the Journal of the North American Menopause Society·Alex SanjuánJuan Antonio Vanrell
Sep 10, 2002·Menopause : the Journal of the North American Menopause Society·Göran SamsioeSören Larsen
Jan 12, 2008·Menopause : the Journal of the North American Menopause Society·Susan H PedersenBent Ottesen
Nov 1, 2006·Women's Health·Giuseppe Mc RosanoGiuseppe Mercuro
Jul 21, 2004·Climacteric : the Journal of the International Menopause Society·S H PedersenB Ottesen
Apr 7, 2009·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Susan Helene PedersenBent Ottesen
Apr 17, 2001·American Journal of Obstetrics and Gynecology·R A Wild, S E Reis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.